Skip to content
Home/Companies/Healthcare/Yukin Therapeutics

Yukin Therapeutics

Healthcare·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Yukin Therapeutics?

Yukin Therapeutics is currently owned by AdBio Partners through AFB Seed-Fund (2017 vintage), since 2019.

Hand-verified · updated 2026-05-24

AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorHealthcare
StatusActive

More from AFB Seed-Fund

Other portfolio companies in the same fund.

Alderaan Biotechnology
Active
HealthcareFrance· 2020
ARTHEx Biotech
ARTHEx Biotech
Active
HealthcareSpain· 2020
GAMUT Therapeutics
Exited 2021
BiotechFrance· 2020
to
Kalsiom
Kalsiom
Active
HealthcareFrance· 2020
Wellium
Active
HealthcareFrance· 2020
Agomab Therapeutics
Agomab Therapeutics
Exited 2026
HealthcareBelgium· 2019
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Yukin Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Yukin Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue